Accordingly, −15C to −15T mutation in the promoter region of inhA and S94A (serine to alanine) and I194T (isoleucine to threonine) mutations in the gene product InhA were found to confer high-level resistance against INH and ETH in MDR-TB (Machado et al., 2013). The gene discussed is INHA; the disease is tuberculosis.